Substantial evidence highlights the role of FOXM1 in cancer development: significant expression in a variety of human cancers [44], poor prognosis of most solid tumors with FOXM1 overexpression [45], and the attenuation of angiogenesis, metastatic potential, and proliferation in some cancer types as a result of FOXM1 inhibition [46]. Here, FOXM1 is linked to cancer.